Effects of hepatitis B virus infection and antiviral therapy on the clinical prognosis of nasopharyngeal carcinoma

ConclusionsHepatitis B virus infection is an independent risk factor for early stage NPC, which may be associated with its reduced immune functions compared to the HBsAg( −) group. Anti‐HBV treatment may improve the prognosis of HBV‐infected NPC patients.

Source: Cancer Medicine - November 26, 2019 Category: Cancer & Oncology Authors: Jing ‐Jin Weng, Jia‐Zhang Wei, Min Li, Jin‐Long Lu, Yang‐Da Qin, He Jiang, Shen‐Hong Qu Tags: ORIGINAL RESEARCH Source Type: research